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and Ana Langer, MD*†
Abstract: This themed supplement to JAIDS: Journal of Acquired
Immune Deﬁciency Syndromes focuses on the critical intersections
between HIV, reproductive, and maternal health services in the health
systems of sub-Saharan Africa. The epidemiology of HIV among
women of reproductive age on the sub-continent demands a holistic
conceptualization and comprehensive approaches to ensure that HIV,
reproductive, and maternal health are optimally addressed. Yet, in
many instances, the national and global responses to these health
issues remain siloed. Women’s health needs and new global and
national guidelines for HIV treatment raise important policy, program-
matic, and operational questions regarding service integration, scale-
up, and health systems functioning. In June 2013, the Maternal Health
Task Force at the Harvard School of Public Health, the United States
Agency for International Development, and the United States Centers
for Disease Control and Prevention convened an international techni-
cal meeting of researchers, policymakers, and practitioners to discuss
the existing evidence base about the interconnections between HIV,
reproductive, and maternal health and identify the most important
knowledge gaps and research priorities. The articles in this special
issue deepen and expand on those discussions by (1) providing empir-
ical evidence about challenges, (2) identifying how improving clinical
care and models of service delivery, strengthening health systems, and
addressing social dynamics can contribute to better outcomes, and (3)
mapping future research directions. Together, these articles underscore
that new policy frameworks and integrated approaches are necessary
but not sufﬁcient to address health system challenges. Addressing the
multiple needs of women of reproductive age who are living with HIV
or are at risk of acquiring HIV is a complex undertaking that requires
improved access to, utilization and quality of comprehensive women’s
healthcare. Continued evaluation and knowledge generation are
needed to ensure that potential health gains are actualized.
Key Words: HIV, women’s health, reproductive health, maternal
health, sub-Saharan Africa, research priorities, integration
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INTRODUCTION
The epidemiology of HIV motivates a focus on the
intersections between HIV, reproductive, and maternal health in
sub-Saharan Africa. Of all pregnancies among women living
with HIV worldwide, 90% occur in sub-Saharan Africa.
1 The
rate of new HIV infections among young African women con-
tinues to be very high in many communities.
2 In high-burden
countries, such as South Africa, Botswana, and Swaziland, the
most recent antenatal care HIV surveys indicate that around 1
in 3 pregnant women are living with HIV.
3–5 Furthermore,
without timely access to antiretroviral therapy (ART), women
with HIV are 6–8 times more likely than HIV-negative women
to die during pregnancy and the postpartum period.
6–8
These statistics should serve as a clarion call to deliver
on the commitments that national governments and the
international community have made to respond to HIV and
improve reproductive and maternal health for women in sub-
Saharan Africa. We will not turn the tide of the HIV
pandemic,
9 achieve universal access to reproductive health
services,
9 and eliminate preventable maternal mortality
10,11
without improving the availability, accessibility, acceptabil-
ity, and quality of maternal, reproductive, and HIV care and
treatment for women who are living with HIV. It is unlikely
that needed improvements will be possible with the siloed
approaches to HIV, reproductive, and maternal health that
many countries and international initiatives continue to fund.
Reﬂecting this understanding, the ﬁelds of HIV,
reproductive, and maternal health were closely linked in the
2013 WHO Consolidated Guidelines on the Use of Antire-
troviral Drugs for Treating and Preventing HIV Infection,
which recommend initiation on lifelong ART for pregnant
and breastfeeding women and for people living with HIV in
serodiscordant relationships.
12 The new guidelines and their
adoption raise important policy, programmatic, and opera-
tional questions regarding service integration, scale-up, and
health systems functioning. In a rapidly changing policy and
practice environment, there is a need for evidence to inform
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In an effort to identify some of the most critical
knowledge gaps in this area, in June 2013, the Maternal Health
Task Force at the Harvard School of Public Health, the United
States Agency for International Development, and the United
States Centers for Disease Control and Prevention brought
together international researchers, policymakers, and practi-
tioners to discuss the existing evidence base and to identify
research priorities for HIV and maternal health (www.mhtf.org).
This themed supplement brings together articles that deepen and
expand on the discussions during that meeting; they provide new
evidence to ﬁll priority knowledge gaps, and map future direc-
tions for research and evaluation.
OVERVIEW OF THE THEMED SUPPLEMENT
The conceptual framework described by Kendall et al
13
identiﬁes 3 areas that organize this supplement: the “individual
level” focuses on clinical management and individual health
outcomes; the “health system” level encompasses synergies
in service delivery and challenges and constraints at different
levels of the health system; and ﬁnally the “society” level ana-
lyzes dimensions of the social environment within and beyond
healthcare institutions that facilitate or impede women’su s eo f
essential HIV and reproductive health services.
Individual Level: Health Status and Clinical
Interventions to Improve the Health of
Women of Reproductive Age Living with HIV
The analysis by Oloﬁne ta l
14 of a randomized controlled
trial among women living with HIV of reproductive age in
a malaria endemic area found that multivitamin supplementation
signiﬁcantly reduced the risk of malaria, reinforcing previous
ﬁndings on the value of vitamin supplements as a low-cost
means of improving both maternal and neonatal outcomes.
An analysis of depression among women living with HIV
during pregnancy and the postpartum period compared with
nonpregnancy-related periods conducted by Kaida et al found no
difference in depression symptom severity. However, very high
levels of depression among women at ART initiation (39%) and
persistently over the study period indicate the need for simpliﬁed
depression screening, and provision of support services at
primary care level and linkage to mental health services as
a key component of HIV treatment and care.
15 Encouragingly,
similar to other studies, the authors found that increased time on
ART, viral suppression, and better physical health were associ-
ated with decreased severity of depressive symptoms.
Health System: Innovations and Challenges in
the Delivery of HIV, Reproductive, and
Maternal Health Services
Five articles in this special issue provide empirical
evidence on synergistic opportunities and health system
challenges related to the demand for and provision of HIV,
reproductive, and maternal health services in sub-Saharan
Africa. The ﬁrst 2 articles analyze efforts to strengthen
prevention of vertical HIV transmission and provision of
ART to pregnant and breastfeeding women as a component of
maternal healthcare, whereas the latter articles focus on
reproductive health services as part of HIV care.
Kieffer et al
16 review early experiences with initiating all
pregnant and breastfeeding women on lifelong ART (Option
B+) in 11 sub-Saharan African countries. Initiation of ART
without requiring CD4 counts resulted in rapid expansion in
the proportion of pregnant and breastfeeding women on ART
but demanded signiﬁcant investment in facility readiness, mon-
itoring and evaluation, and expansion of health worker capac-
ity. The authors also identiﬁed barriers to acceptance of lifelong
treatment and retention after antenatal diagnosis among women
l i v i n gw i t hH I V .I nap r o c e s se v a l u a t i o ni nu r b a nT a n z a n i a ,
Lema et al
17 found that community health workers performed
well at identifying women early during pregnancy—a result
that points to the potential of using community health workers
to improve timely uptake of antenatal care and prevention of
mother-to-child HIV transmission (PMTCT).
The next 3 articles underline the need, as well as
opportunities, to address the sexual and reproductive health
(SRH) of women living with HIV and their partners as an
integral component of HIV care. Among a sample of recently
diagnosed inconsistent condom users who were not yet taking
antiretroviral treatment, Mantell et al
18 found that 40% intended
to become pregnant within the next 6 months with signiﬁcant
differences between men (60%) vs. women (21%). Their analy-
sis highlights the urgency of routinely addressing reproductive
health early in the HIV treatment cascade, responding to the
reproductive health needs and expectations of men and women,
and attending to gender in reproductive health counseling.
Unmet need and the complexities of providing high-quality
reproductive health information and services are illustrated by
Matthews et al
19 ﬁnding that HIV healthcare providers do not
regularly assess fertility intentions and have only partial knowl-
edge of safer conception strategies for HIV serodiscordant cou-
ples, leading to missed opportunities to adequately support
reproductive desires and prevent HIV acquisition among HIV-
negative partners. Although these ﬁndings point toward needed
improvements in the delivery of reproductive health services for
people living with HIV and their partners, Raifman et al
20 found
that condom use (alone and in combination with other contra-
ceptive methods) increased as women living with HIV advanced
along the HIV treatment cascade from learning their HIV status
to ART initiation and long-term treatment retention. These re-
sults indicate the importance of HIV interventions as a platform
for providing reproductive and sexual health services and suggest
that HIV treatment and care programs can make important con-
tributions to HIV prevention by inﬂuencing contraceptive behav-
iors. These 5 articles identify beneﬁts of and challenges to
integrating HIV care and treatment with reproductive and mater-
nal health services, needed actions, and innovative solutions.
Society: Addressing Social Dimensions of
Uptake and Retention in HIV and Maternal
Health Services
Finally, 3 articles analyze dimensions of the social
relationships that may impede or facilitate women’s uptake of
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methods study by Sando et al
21 explored disrespect and abuse
experienced by women living with HIV and HIV-negative
women during childbirth. Although rates of reported and
observed disrespect and abuse were high, few signiﬁcant dif-
ferences were observed between women living with HIV and
HIV-negative women. The narratives of healthcare providers
suggested that training and supervision focused on ensuring
nondiscrimination toward women living with HIV as part of
the PMTCT program, has created an institutional culture
where overt discrimination based on HIV status is unaccept-
able. The authors conclude that similar initiatives could be
used to ensure respectful maternity care for all women.
Articles from Spangler et al and Myer et al provide
novel data about the importance of engaging with family and
other community members to support uptake of maternal
health interventions and to contribute to retention of women
in long-term HIV care and treatment. In rural Kenya,
Spangler et al
22 found that women living with HIV who
had not yet disclosed their status to anyone had the lowest
levels of maternity and PMTCT service utilization. Any dis-
closure of status increased the probability of facility-based
birth and use of ARVs; disclosure to the male partner was
found to have a particularly strong effect on increasing ARV
use for PMTCT among women living with HIV. Myer et al
examined the association of family members’ ART co-
enrollment with retention. They found that risk of loss to
follow-up was highest among women who did not have
a co-enrolled family member.
23 Together, these 3 articles pro-
vide compelling evidence of the importance of addressing the
social environment to improve uptake of and retention in HIV
and maternal health services.
STRENGTHENING THE EVIDENCE BASE
The limited information on the intersections between
HIV, reproductive, and maternal health—including the
paucity of data on cause of maternal morbidity and mortality
among women with HIV and lack of evidence on successful
models to effectively integrate HIV and reproductive health—
are threads that run through this themed supplement.
Improvement of vital registration, harmonization of data col-
lection, and inclusion of key indicators by HIV, reproductive,
and maternal health programs in monitoring and evaluation
are essential to advance the evidence base. One example
where substantial improvements in data availability are pos-
sible and hold great potential for strengthening the evidence
base is the systematic review of the causes and circumstances
of maternal deaths in the health systems of sub-Saharan
African countries. Kendall et al
13 outline both broad and speciﬁc
research questions critical for addressing the leading causes of
maternal death and improving the clinical management of
women living with HIV, as well as for evaluating promising
interventions to create an enabling social environment for
women to begin and remain in HIV and maternal health
services. Kendall et al also identify priorities for research
and evaluation on integration of HIV, maternal, and SRH at
the “micro level” of health services, whereas Hope et al do the
same at the “macro level” of national health systems in sub-
Saharan Africa. Despite national and global policies advocat-
ing for integration, there is surprisingly little empirical
evidence on the outcomes of integrated programs for service
users, healthcare providers, or the broader health system. The
article by Kendall et al
13 identiﬁes key questions about the
integration of HIV and maternal health services, as well as
how to provide additional services such as prevention and
treatment of malaria and tuberculosis to pregnant women
living with HIV. The scoping study conducted by Hope
et al summarizes recommendations for integration of HIV
with SRH services based on 5 national case studies and iden-
tiﬁes priorities for health systems research on governance,
policy and planning, ﬁnancing, the health workforce, service
organization, and monitoring and evaluation.
24 Implementing
more rigorous intervention studies, building robust evaluation
designs into ongoing efforts to integrate HIV and reproduc-
tive health services, and focusing on higher level transforma-
tion of the health system, for example through integration of
ﬁnancing mechanisms or monitoring and evaluation systems,
are some of the key priorities for future research. As interna-
tional development agencies, donors, and national govern-
ments in sub-Saharan Africa increasingly commit to funding
integrated SRH and HIV services, it is urgent to generate
empirical evidence about whether, when and how such inte-
gration can improve health and health systems outcomes.
CONCLUSIONS
This collection of articles highlights the need to
conceptualize HIV, reproductive, and maternal health holis-
tically and identiﬁes how improving clinical care and
models of service delivery, strengthening health systems,
and addressing social dynamics can contribute to better
outcomes. Together, these articles underscore that new
policy frameworks and integrated approaches are necessary
but not sufﬁcient to successfully address health system
challenges. Addressing the multiple needs of women of
reproductive age in sub-Saharan Africa with regard to HIV,
maternal and reproductive health is a complex undertaking.
Progress toward the global health goals of reducing the
burden of HIV and promoting maternal and reproductive
health will require improved access to, utilization and
quality of comprehensive women’s healthcare, continued
knowledge generation, and evaluation to chart progress.
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